The FDA expanded Casgevy, the first CRISPR gene therapy, to children as young as two. The edit takes hours. The conditioning takes everything. To g...
Compass Pathways released six-month data from its second Phase 3 trial of COMP360 psilocybin for treatment-resistant depression. Thirty-nine percen...